Thermo Fisher Scientific (TMO) Tops Q1 EPS by 40c, raises guidance

Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $5.11, $0.40 better than the analyst estimate of $4.71. Revenue for the quarter came in at $10.34 billion versus the consensus estimate of $10.16 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2024 EPS of $21.14-$22.02, versus the consensus of $21.53. Thermo Fisher Scientific sees FY2024 revenue of $42.3-43.3 billion, versus the consensus of $42.83 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c